Results 161 to 170 of about 464,004 (267)

Risk factors for relapse in ANCA‐associated vasculitis among patients with relapse after induction of remission with rituximab

Arthritis &Rheumatology, Accepted Article.
Objective To determine risk factors for relapse of ANCA‐associated vasculitis (AAV) after re‐induction of remission with rituximab and discontinuation of maintenance therapy. Methods This is a post‐hoc analysis of the RITAZAREM clinical trial. Patients 15 years or older with AAV and a positive test for anti‐proteinase‐3 (PR3‐) or anti‐myeloperoxidase ...
Ellen Romich, Joshua F. Baker, Thomas R. Riley IV, Ian Green, Rennie L. Rhee, Carol A. McAlear, Ulrich Specks, Rona M. Smith, David R. Jayne, Peter A. Merkel, for the RITAZAREM Investigators   +10 more
wiley   +1 more source

Mechano-energetic uncoupling in the right ventricle in pulmonary hypertension. [PDF]

JHLT Open
Zhang P, Avazmohammadi R, Prins KW, Choudhary G.   +3 more
europepmc   +1 more source

A Novel Clinical Prediction Model for Pulmonary Hypertension Based on Computed Tomography Angiography, Laboratory Data, and basic demographic information [PDF]

Cheng Qian, Xiaojun Hao, Hao Li, Hongxia Jiang   +3 more
openalex   +1 more source

A modified risk score in one-year survival rate assessment of group 1 pulmonary arterial hypertension [PDF]

, 2018
Wei Xiong, Yunfeng Zhao, Mei Xu, Bigyan Pudasaini, Xuejun Guo, Jinming Liu   +5 more
openalex   +1 more source

Long‐Term Outcomes of Reduced Intensity Conditioning Hematopoietic Stem Cell Transplantation for Systemic Sclerosis Patients with Impaired Cardiac Function

Arthritis &Rheumatology, Accepted Article.
Objective High intensity conditioning autologous hematopoietic stem cell transplantation (AHSCT) is standard of care for patients with advanced SSc. The role of reduced intensity conditioning (RIC) prior to AHSCT in this population remains unclear. We conducted this study to determine the long‐term outcomes of RIC AHSCT in SSc patients with cardiac ...
Yonatan Lean, Carrie Richardson, Anthony Esposito, Katy Bedjeti, George E. Georges   +4 more
wiley   +1 more source

The Discovery of Inhaled Prostanoids for Pulmonary Hypertension. [PDF]

Pulm Circ
Seeger W.
europepmc   +1 more source

How to Assess Impaired Right Heart Electrical Conduction in Patients with Pulmonary Arterial Hypertension? [PDF]

Naoya Kataoka, Teruhiko Imamura
openalex   +1 more source

Idiopathic pulmonary arterial hypertension – a unrecognized cause of high‐shear high‐flow haemostatic defects (otherwise referred to as acquired von Willebrand syndrome) in children [PDF]

, 2018
Marie‐Claude Pelland‐Marcotte, Tilman Humpl, Paula D. James, Margaret L. Rand, Vanessa Bouskill, Janette T. Reyes, Mackenzie Bowman, Manuel Carção   +7 more
openalex   +1 more source

The integration of the British Pharmacological Society's prescription safety assessment into the WHO 6‐step model of rational pharmacotherapy in a Turkish medical school

British Journal of Clinical Pharmacology, EarlyView.
Aims At Koç University School of Medicine, a one‐week rational pharmacotherapy (RPHM) programme, modelled after WHO 6‐step, has been introduced in the fourth‐year curriculum to improve prescription skills. For efficient problem‐based learning (PBL) sessions on a prespecified topic, students need to brush up on basic pharmacology knowledge, so we ...
Sinem Ezgi Gülmez, Gülnihal Özcan, Hakan S. Orer   +2 more
wiley   +1 more source

Telangiectasias as a Forerunner of Pulmonary Hypertension. [PDF]

Dtsch Arztebl Int
Ullrich FTH, Thaler MB, Schulze-Koops H.
europepmc   +1 more source